Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures
Biomolecules · 2025
DOI: 10.3390/biom15111575 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Biomolecules, 2025. Verfasst von Cristina-Paula Ursu und 12 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Surgery Department, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Lipidomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy "Iuliu Hațieganu", Cluj-Napoca, România, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania Doctoral Research Program.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), the most common primary liver malignancy, usually develops in patients with cirrhosis, yet the metabolic mechanisms that distinguish the two conditions remain poorly understood. This study aimed to explore metabolic dysregulations in HCC compared with cirrhosis and to identify potential biomarkers, especially lipids, with diagnostic and prognostic value. We prospectively studied 81 patients—41 with HCC and 40 with cirrhosis—using high-resolution UHPLC-QTOF-ESI+-MS to characterize their serum lipidome. Across both groups, 322 metabolites were identified, but their distribution was strikingly different. Patients with HCC showed higher levels of sphingolipids, glycerophospholipids, diglycerides, sterols, and certain fatty acids, reflecting tumor-related metabolic rewiring. In contrast, cirrhotic patients had increased D-glucose, 5-hydroxymethyluracil, lysophospholipids, acylcarnitines, and specific fatty acid derivatives. Several lipids, such as CerPE(d16:2/24:1(2OH)), SM(d18:0/14:0), PA(36:6), and GlcCer(d18:1/12:0), displayed excellent discriminative accuracy, highlighting their role as putative biomarkers. These findings underscore the importance of lipid metabolic reprogramming in HCC, characterized by membrane remodeling, energy adaptation, and oxidative stress resistance. Integrating lipidomic profiling into clinical practice could improve early detection and risk stratification in cirrhotic patients. Larger, multicenter studies are needed to validate these biomarkers and assess their therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 3rd Surgery Department, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
- "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
- 3rd Medical Department, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
- Department of Surgery-Practical Skills, "Iuliu Hațieganu" University of Medicine and Pharmacy, Marinescu Street No. 23, 400337 Cluj-Napoca, Romania.
- Department of Community Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, Avram Iancu Street, No. 31, 400347 Cluj-Napoca, Romania.
- Center for Applied Biotechnology Biodiatech, SC Proplanta, 400478 Cluj-Napoca, Romania.
ORCID-Profile: Cristina-Paula Ursu, Răzvan Alexandru Ciocan, Ștefan Ursu, Claudia Diana Gherman, Dan Vălean, Rodica Sorina Pop, Horia Ștefănescu, Carmen Socaciu, Nadim Al Hajjar, Florin Graur
Förderung
- University of Medicine and Pharmacy "Iuliu Hațieganu", Cluj-Napoca, România
- “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania Doctoral Research Program
Zitieren
APA
Ursu, C. P., Furcea, L. E., Procopeț, B., Ciocan, R. A., Ursu, Ș., Gherman, C. D., Vălean, D., Pop, R. S., Moiș, E. I., Ștefănescu, H., Socaciu, C., Al Hajjar, N., & Graur, F. (2025). Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures. Biomolecules. https://doi.org/10.3390/biom15111575
Vancouver
Ursu CP, Furcea LE, Procopeț B, Ciocan RA, Ursu Ș, Gherman CD, et al. Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures. Biomolecules. 2025. doi:10.3390/biom15111575
BibTeX
@article{Ursu2025,
author = {Ursu, Cristina-Paula and Furcea, Luminița Elena and Procopeț, Bogdan and Ciocan, Răzvan Alexandru and Ursu, Ștefan and Gherman, Claudia Diana and Vălean, Dan and Pop, Rodica Sorina and Moiș, Emil Ioan and Ștefănescu, Horia and Socaciu, Carmen and Al Hajjar, Nadim and Graur, Florin},
title = {Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15111575}
}
EUVIMED